Lambrinex

Atorvastatin, the active ingredient in Lambrinex, is a HMG‑CoA reductase inhibitor presented as an oral tablet for oral use. It treats hypercholesterolemia and related lipid disorders in adults.\n\nGNH India supplies Lambrinex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Atorvastatin is indicated for disorders of lipid metabolism and cardiovascular risk reduction.\n\nHypercholesterolemia: lowers low‑density lipoprotein (LDL) cholesterol to reduce atherosclerotic risk.\nMixed dyslipidemia: improves the overall lipid profile by decreasing LDL and triglycerides while modestly raising HDL.\nCardiovascular event prevention: used as part of secondary prevention strategies to lower the incidence of myocardial infarction, stroke and related events.

Common Side Effects:\n- Muscle aches or weakness\n- Elevated liver enzymes\n- Gastrointestinal discomfort such as nausea or abdominal pain\n- Headache\n- Dizziness\n- Fatigue\n\nSerious or Rare Side Effects:\n- Rhabdomyolysis leading to renal failure\n- Severe hepatic injury\n- Anaphylactic or severe allergic reactions\n- Myopathy with marked CK elevation\n- Acute pancreatitis\n- Thrombocytopenia

Atorvastatin requires careful monitoring and patient counseling before initiation.\n\nLiver function monitoring: obtain baseline and periodic hepatic enzyme tests.\nMuscle symptom assessment: educate patients to report unexplained muscle pain or weakness.\nDrug interaction review: evaluate concomitant medications that affect CYP3A4.\nRenal impairment caution: adjust dosing in patients with significant renal dysfunction.\nPregnancy and lactation: avoid use unless benefits outweigh potential risks.\nStore at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Atorvastatin may interact with several drug classes, necessitating vigilance.\n\nMajor Interactions (Avoid):\n- Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole, HIV protease inhibitors)\n- Grapefruit juice\n- Cyclosporine\n- Gemfibrozil\n- High‑dose niacin\n\nModerate Interactions (Monitor Closely):\n- Warfarin (potential INR elevation)\n- Digoxin (possible increased serum levels)\n- Other statins (combined risk of myopathy)\n- Antihypertensives (enhanced hypotensive effect)\n- Antidiabetic agents (possible glucose alterations)